AR038849A1 - Uso de ribozimas en la deteccion de agentes adventicios - Google Patents
Uso de ribozimas en la deteccion de agentes adventiciosInfo
- Publication number
- AR038849A1 AR038849A1 ARP030100637A ARP030100637A AR038849A1 AR 038849 A1 AR038849 A1 AR 038849A1 AR P030100637 A ARP030100637 A AR P030100637A AR P030100637 A ARP030100637 A AR P030100637A AR 038849 A1 AR038849 A1 AR 038849A1
- Authority
- AR
- Argentina
- Prior art keywords
- reovirus
- composition
- ribozyme
- ribozimas
- adventive
- Prior art date
Links
- 238000001514 detection method Methods 0.000 title 1
- 241000702263 Reovirus sp. Species 0.000 abstract 4
- 102000053642 Catalytic RNA Human genes 0.000 abstract 3
- 108090000994 Catalytic RNA Proteins 0.000 abstract 3
- 108091092562 ribozyme Proteins 0.000 abstract 3
- 238000003776 cleavage reaction Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 231100000255 pathogenic effect Toxicity 0.000 abstract 1
- 230000007017 scission Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
- C12N2310/121—Hammerhead
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2521/00—Reaction characterised by the enzymatic activity
- C12Q2521/30—Phosphoric diester hydrolysing, i.e. nuclease
- C12Q2521/337—Ribozyme
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/14—Reoviridae, e.g. rotavirus, bluetongue virus, Colorado tick fever virus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Plant Pathology (AREA)
- Oncology (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36073002P | 2002-02-28 | 2002-02-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR038849A1 true AR038849A1 (es) | 2005-01-26 |
Family
ID=27766245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030100637A AR038849A1 (es) | 2002-02-28 | 2003-02-26 | Uso de ribozimas en la deteccion de agentes adventicios |
Country Status (16)
| Country | Link |
|---|---|
| EP (2) | EP1481084B1 (enExample) |
| JP (3) | JP4369243B2 (enExample) |
| AR (1) | AR038849A1 (enExample) |
| AT (1) | ATE519860T1 (enExample) |
| AU (1) | AU2003206587B2 (enExample) |
| BR (1) | BR0307882A (enExample) |
| CA (1) | CA2374388C (enExample) |
| DE (1) | DE03704136T1 (enExample) |
| DK (1) | DK1481084T3 (enExample) |
| ES (1) | ES2241506T3 (enExample) |
| MX (1) | MXPA04008277A (enExample) |
| NZ (1) | NZ534488A (enExample) |
| TR (1) | TR200501513T3 (enExample) |
| TW (1) | TWI329132B (enExample) |
| WO (1) | WO2003072811A2 (enExample) |
| ZA (1) | ZA200406231B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1306959C (zh) * | 2004-09-21 | 2007-03-28 | 中国科学院武汉病毒研究所 | 草鱼呼肠孤病毒抗原亚单位疫苗制备方法 |
| WO2007099401A2 (en) | 2005-08-01 | 2007-09-07 | University Technologies International, Inc. | Oncolytic attenuated reoviruses for treatment of proliferative disorders |
| US10668119B2 (en) | 2005-08-01 | 2020-06-02 | Virocure, Inc. | Attenuated reovirus |
| US10369171B2 (en) | 2007-03-13 | 2019-08-06 | Virocure, Inc. | Attenuated reoviruses for selection of cell populations |
| TWI597499B (zh) * | 2009-05-28 | 2017-09-01 | 亞培生物股份有限公司 | 體外病原體檢驗技術 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4987071A (en) | 1986-12-03 | 1991-01-22 | University Patents, Inc. | RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods |
| US5254678A (en) | 1987-12-15 | 1993-10-19 | Gene Shears Pty. Limited | Ribozymes |
| US5168053A (en) | 1989-03-24 | 1992-12-01 | Yale University | Cleavage of targeted RNA by RNAase P |
| US5225347A (en) | 1989-09-25 | 1993-07-06 | Innovir Laboratories, Inc. | Therapeutic ribozyme compositions and expression vectors |
| US5225337A (en) | 1989-09-25 | 1993-07-06 | Innovir Laboratories, Inc. | Ribozyme compositions and methods for use |
| US5631115A (en) | 1992-07-02 | 1997-05-20 | Sankyo Company, Limited | Looped, hairpin ribozyme |
| EP0707638A4 (en) * | 1992-12-04 | 1998-05-20 | Innovir Lab Inc | REGULATABLE THERAPEUTIC NUCLEIC ACID AND METHOD FOR THE USE THEREOF |
| DE69426841T2 (de) | 1993-02-16 | 2001-09-06 | Onyx Pharma Inc | Cytopatische Viren zur Therapie und Prophylaxe der Neoplasie |
| ES2196026T3 (es) | 1993-04-30 | 2003-12-16 | Wellstat Biologics Corp | Uso de ndv en la fabricacion de un medicamento para tratar el cancer. |
| AU5334294A (en) * | 1993-10-15 | 1995-05-04 | Dkfz Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts | Asymmetric hammerhead ribozymes and nucleotide sequences for their construction |
| US5631359A (en) | 1994-10-11 | 1997-05-20 | Ribozyme Pharmaceuticals, Inc. | Hairpin ribozymes |
| US6107027A (en) * | 1994-12-14 | 2000-08-22 | University Of Washington | Ribozymes for treating hepatitis C |
| US6136307A (en) | 1997-08-13 | 2000-10-24 | Oncolytics Biotech Inc. | Reovirus for the treatment of cellular proliferative disorders |
| US6110461A (en) * | 1997-08-13 | 2000-08-29 | Oncolytics Biotech Inc. | Reovirus for the treatment of neoplasia |
| NZ550147A (en) | 1997-10-09 | 2008-09-26 | Wellstat Biologics Corp | Treatment of neoplasms with viruses |
| WO1999050277A1 (en) | 1998-03-28 | 1999-10-07 | University Of Utah Research Foundation | Circular, hairpin, circular/hairpin, lariat, and hairpin-lariat hammerhead ribozymes |
| AU6522599A (en) * | 1998-10-23 | 2000-05-15 | Children's Medical Center Corporation | Use of a self-cleaving rna motif to modulate gene expression |
| US7122645B2 (en) | 2000-03-27 | 2006-10-17 | Smithkline Beecham Corporation | Detection of viable agents |
| TWI289158B (en) * | 2000-08-10 | 2007-11-01 | Oncolytics Biotech Inc | Method of producing infectious reovirus |
-
2002
- 2002-03-04 CA CA002374388A patent/CA2374388C/en not_active Expired - Fee Related
-
2003
- 2003-02-25 TW TW092103911A patent/TWI329132B/zh not_active IP Right Cessation
- 2003-02-26 AU AU2003206587A patent/AU2003206587B2/en not_active Ceased
- 2003-02-26 DK DK03704136.5T patent/DK1481084T3/da active
- 2003-02-26 TR TR2005/01513T patent/TR200501513T3/xx unknown
- 2003-02-26 DE DE03704136T patent/DE03704136T1/de active Pending
- 2003-02-26 MX MXPA04008277A patent/MXPA04008277A/es active IP Right Grant
- 2003-02-26 AT AT03704136T patent/ATE519860T1/de not_active IP Right Cessation
- 2003-02-26 JP JP2003571491A patent/JP4369243B2/ja not_active Expired - Fee Related
- 2003-02-26 ES ES03704136T patent/ES2241506T3/es not_active Expired - Lifetime
- 2003-02-26 EP EP03704136A patent/EP1481084B1/en not_active Expired - Lifetime
- 2003-02-26 AR ARP030100637A patent/AR038849A1/es unknown
- 2003-02-26 NZ NZ534488A patent/NZ534488A/en unknown
- 2003-02-26 EP EP11176991A patent/EP2439286A1/en not_active Withdrawn
- 2003-02-26 BR BR0307882-5A patent/BR0307882A/pt not_active IP Right Cessation
- 2003-02-26 WO PCT/CA2003/000264 patent/WO2003072811A2/en not_active Ceased
-
2004
- 2004-08-04 ZA ZA2004/06231A patent/ZA200406231B/en unknown
-
2008
- 2008-09-12 JP JP2008235697A patent/JP2009005712A/ja not_active Withdrawn
-
2012
- 2012-03-29 JP JP2012077593A patent/JP5615865B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2241506T1 (es) | 2005-11-01 |
| TR200501513T3 (tr) | 2005-06-21 |
| EP2439286A1 (en) | 2012-04-11 |
| JP2005518797A (ja) | 2005-06-30 |
| CA2374388C (en) | 2005-07-12 |
| AU2003206587B2 (en) | 2007-03-15 |
| AU2003206587A1 (en) | 2003-09-09 |
| HK1067664A1 (en) | 2005-04-15 |
| JP2009005712A (ja) | 2009-01-15 |
| JP4369243B2 (ja) | 2009-11-18 |
| EP1481084B1 (en) | 2011-08-10 |
| DE03704136T1 (de) | 2005-12-15 |
| TW200404099A (en) | 2004-03-16 |
| BR0307882A (pt) | 2004-12-28 |
| WO2003072811A3 (en) | 2004-02-05 |
| WO2003072811A2 (en) | 2003-09-04 |
| ATE519860T1 (de) | 2011-08-15 |
| ES2241506T3 (es) | 2011-12-13 |
| JP2012125257A (ja) | 2012-07-05 |
| TWI329132B (en) | 2010-08-21 |
| JP5615865B2 (ja) | 2014-10-29 |
| EP1481084A2 (en) | 2004-12-01 |
| DK1481084T3 (da) | 2011-09-26 |
| ZA200406231B (en) | 2005-11-30 |
| CA2374388A1 (en) | 2003-08-28 |
| NZ534488A (en) | 2008-04-30 |
| MXPA04008277A (es) | 2004-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2190727B1 (es) | Dispositivo para formar y/o aumentar el numero relativo de celulas indiferenciadas en una poblacion celular y procedimientos correspondientes. | |
| MXPA03003281A (es) | Deteccion enzimatica no invasiva de estados asociados con la remodelacion de tejidos. | |
| AR043150A1 (es) | Composicion oral que contiene enzimas con estabilidad mejorada | |
| CO5271708A1 (es) | Ensayo y metodos basados en el uso de canales de sodio como objetivos de amiloide b o de sus agregados | |
| SV2002000343A (es) | Composisiones farmaceuticas de inhibidores de la glucogeno fosforilasa ref. pc10882/20147/bb | |
| BR0215405A (pt) | Composições e processos de uso de collajolie | |
| AR040625A1 (es) | Metodo y sistema para detectar datos incluidos en los datos de audio como una corriente continua de mensajes codificados. | |
| CL2009000843A1 (es) | Metodo para tratar cancer en un paciente que comprende la administracion de un primer agente que es inhibidor de factor de crecimiento de hepatocito (hgf) en combinacion con un segundo agente que es inhibidor de una ruta de senalizacion celular diferente de la ruta hgf/cmet. | |
| CO5780138A1 (es) | Dispositivo y metodo para rapidamente determinar la efectividad del procedimiento de esterilizacion o desinfeccion | |
| CL2008001072A1 (es) | Bloque de limpieza de inodoro que es al menos parcialmente transparente o translucida, que comprende 2 - 50% de material biocida y 50 - 98% de composicion portadora que comprende 5 - 50% de agente jabon, 30 - 90% de humectante, 5 - 30% de solvente; metodo para proporcionar higiene en un inodoro; y uso del bloque | |
| AR034200A1 (es) | Agente para el cuidado de lentes de contacto, su uso, y procedimiento de limpieza | |
| AR110174A2 (es) | Agentes endoparasiticidas y procedimiento de preparación | |
| AR038849A1 (es) | Uso de ribozimas en la deteccion de agentes adventicios | |
| ECSP077920A (es) | Dispositivo de ensayo | |
| AR058959A1 (es) | Metodos para modular receptores de la superficie celular para prevenir o reducir la inmflamacion | |
| ECSP055718A (es) | Composicion limpiadora que contiene un polimero hidrofilizado | |
| CL2012002871A1 (es) | Metodo para identificar una población de celulas tr1 en reposo que comprende la deteccion de la expresion en la superficie celular de los marcadores cd4, cd25, cd127 y cd62l; poblacion aislada de celulas tr1; metodo para disminuir una poblacion de celulas tr1; kit para identificar o aislar una poblacion de celulas tr1 en reposo y/o activadas; composicion farmaceutica que comprende una poblacion de celulas tr1 en reposo y/o activadas. | |
| AR029092A1 (es) | Composiciones para el tratamiento del cabello | |
| AR025995A1 (es) | Metodo para determinar la presencia de leptina o de agentes mimeticos de leptina y vector que incluye la secuencia de nucleotidos que codifican la region del promotor ang-2 | |
| ATE406461T1 (de) | Rna-bioassay | |
| ES2128696T3 (es) | Metodo para preparar un catalizador de isomerizacion. | |
| ES2194996T3 (es) | Composiciones y metodos para desinfectar una lente de contacto y detectar la presencia de un desinfectante oxidativo. | |
| AR031404A1 (es) | Una composicion y metodo de aplicacion | |
| AR065703A1 (es) | Uso de una micro - emulsion acuosa para la preparacion de una formulacion para el tratamiento de enfermedades adiposas y dicha micro - emulsion | |
| GT200600522A (es) | Nueva asociación de un inhibidor de la corriente sinusal i, y de un inhibidor de la enzima de conversión y las composiciones farmacéuticas que la contienen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |